We earn commissions from the providers listed here. No provider buys a position, a rating, or a listing. The order is set by hand, and we do not claim it is independent of what we earn. Advertising Disclosure

How Much Does Nutrafol Cost? Pricing Guide (2026)

Nutrafol pricing breakdown: one-time vs subscription cost, per-formula pricing (Men, Women, Women's Balance, Postpartum), and how it compares to prescription hair loss options.

Nutrafol is a dietary supplement, not a prescription medication, so you can buy it without a doctor visit - but that also means insurance rarely helps with the cost. As of September 11, 2026, you pay $79 a month on a monthly subscription, or $88 plus $6.95 shipping for a one-time bottle, the same tier across the core formulas. Below: what each formula costs, how subscription and multi-month plans change the math, and where Nutrafol lands next to prescription options like finasteride. Confirm the exact price at checkout since supplement brands adjust pricing and promos often.

Average Costs Comparison

Two things set your Nutrafol price: which formula you pick, and whether you subscribe or buy once. Here's what you pay across the core line:

ProviderMonthly CostPer DoseConsultationShippingNotes
Nutrafol Men$79/month (subscription) or $88/month (one-time)Not required (over-the-counter dietary supplement, no prescription)Free with subscriptionDesigned for men 18-49. Nutrafol cites a 6-month clinical study (Stephens et al., JCAD, 2022); individual results vary.
Nutrafol Women$79/month (subscription) or $88/month (one-time)Not requiredFree with subscriptionDesigned for women 18-44; same subscription pricing tier as the Men's formula.
Nutrafol Women's Balance / Postpartum$79/month (subscription) or $88 one-time, same tier as the core lineNot requiredFree with subscriptionBalance is designed for women 45+, and Postpartum for the first year after childbirth; as of September 11, 2026 both are priced in the same tier as the core Men's and Women's line.
Nutrafol Men 50+$79/month (subscription) or $88/month (one-time), same core tierNot requiredFree with subscriptionNutrafol cites a 9-month clinical study of 34 men aged 40-65 for this formula; individual results vary.

Top Hair Loss Providers by Value

Our Top Choice
1

FDA-Approved Finasteride and Minoxidil - 100% Online, Free Shipping

  • Finasteride and minoxidil, plus the compounded Hair Hybrids blends, which the FDA has neither approved nor reviewed for safety, effectiveness, or quality
  • Oral finasteride tablets and topical minoxidil hold FDA approval for hair loss; the spray, chew and serum blends are the compounded Hair Hybrids and do not
  • Initial evaluation, ongoing check-ins and provider questions at no extra cost
  • Free shipping to your door - no insurance needed
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Best Value
2

Minoxidil From $12.67/mo - FDA-Approved Hair Regrowth

  • Minoxidil 2% topical solution from $12.67/mo; oral minoxidil from $29/mo, prescribed off-label for hair loss
  • Biotin + Minoxidil gummies and chews from $35/mo, compounded Hair Blends that carry no FDA approval and no FDA review of safety, effectiveness or quality
  • Postmenopausal serum pairing finasteride with minoxidil, a compounded blend; no topical finasteride product is FDA-approved
  • Topical minoxidil holds FDA approval for women's hair regrowth; the multi-ingredient blends do not
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Most Popular
3

Prescription-Strength Hair Regrowth - Free Discreet Shipping

  • Oral finasteride, oral minoxidil and topical minoxidil options
  • FDA-approved finasteride and topical minoxidil; oral minoxidil prescribed off-label
  • 100% online process with unlimited provider messaging
  • Free shipping in discreet packaging
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★

One-Time vs. Subscription vs. Multi-Month Pricing

One-Time Purchase

Buying a single bottle without subscribing is the most expensive way to take Nutrafol. No auto-refill discount, no multi-month break - full price, every time.

Consultation:Not required
Medication:$88/month equivalent, single bottle
Shipping:$6.95
Total:$88/month, highest per-unit cost

Monthly Subscription

Subscribing drops the price to $79/month and includes free shipping. Nutrafol says you can pause or cancel anytime.

Consultation:Not required
Medication:$79/month
Shipping:Free
Total:$79/month on a recurring plan

3- and 6-Month Plans

Nutrafol's multi-month subscriptions cost $224 for a 3-month supply and $422 for a 6-month supply as of September 11, 2026, which Nutrafol labels as saving 15% and 20% against the one-time price.

Consultation:Not required
Medication:$224 per 3 months or $422 per 6 months
Shipping:Free
Total:Lowest per-month cost, largest upfront payment

Does Insurance or HSA/FSA Cover Nutrafol?

Nutrafol is a dietary supplement sold without a prescription, so standard insurance does not cover it and HSA/FSA eligibility is not automatic the way it can be for a prescribed medication.

Commercial Insurance

Coverage: Not covered

Nutrafol is a dietary supplement sold without a prescription, so plan on paying for it out of pocket.

Medicare / Medicaid

Coverage: Not covered

Neither program covers over-the-counter supplements for hair loss.

HSA/FSA

Coverage: Generally not eligible without documentation

IRS Publication 502 says you can't count nutritional supplements as a medical expense unless a medical practitioner recommends them as treatment for a specific condition diagnosed by a physician. Some plans therefore ask for a Letter of Medical Necessity, so confirm with your plan administrator before assuming it qualifies.

Nutrafol vs. Prescription Alternatives: Cost Per Dollar

Nutrafol costs more per month than generic prescription options and works through a different mechanism (nutraceutical vs. DHT-blocking drug), so this is a cost-vs-approach tradeoff, not an apples-to-apples swap. The regulatory status differs too: finasteride 1mg is FDA-approved for male pattern hair loss, while Nutrafol is a dietary supplement - the FDA does not review supplements for effectiveness before they are sold.

MedicationCompounded/GenericBrand-NameSavings
Nutrafol (1 year, subscription)Cost: ~$948/year at $79/month.No prescription required; a dietary supplement (not an FDA-approved drug) with brand-cited clinical studies; individual results vary.Costs more per month than generic finasteride ($16-$20/month at Ro) for a different, non-drug approach.
Generic finasterideCost: $16-$20/month at Ro by plan length; from $22/month at Hims.Requires a prescription; see our finasteride cost guide for full pricing.Lower cost per year than Nutrafol on a standard subscription.

How to Lower Your Nutrafol Cost

  • Treat the one-time price as a tax on not subscribing - subscribe and you pay $79 instead of $88 from your first bottle, and skip the $6.95 shipping on a one-time order.
  • Already know you'll stay on it a while? Pick a 3- or 6-month plan up front; the per-month price drops further on longer commitments.
  • Check for a first-order offer before checkout. As of September 11, 2026, Nutrafol offers $10 off your first subscription order when you join its mailing list, and new subscribers get a free gift set (about $33 value with the men's formulas, $46 with the women's) through November 5, 2026.
  • Confirm current pricing and any active promo directly at checkout before you buy - supplement brands change pricing and offers more often than prescription platforms.
  • If cost is the main driver, compare against generic finasteride or minoxidil (see our hair loss treatment costs guide) since those run cheaper per month, though they work differently and require a prescription for finasteride.

Hidden Costs to Watch For

  • Auto-renewal: subscriptions bill automatically each cycle - cancel ahead of your renewal date if you plan to stop.
  • Shipping on one-time (non-subscription) orders costs $6.95.
  • Multi-month plans require a larger upfront payment even though the effective monthly rate is lower.
  • Results take time - the brand's own studies run 6-9 months, so budget for that full window before judging value, not just one or two months.

Frequently Asked Questions

How much does Nutrafol cost per month?

As of September 11, 2026, Nutrafol runs $79/month on a monthly subscription or $88 plus $6.95 shipping if you buy a single bottle without subscribing. Specialty formulas (Women's Balance, Postpartum) are listed in the same price tier. Confirm the exact price at checkout since it can change.

Is Nutrafol covered by insurance or HSA/FSA?

Insurance rarely covers Nutrafol since it is a dietary supplement, not a prescription drug. HSA/FSA reimbursement is limited too: IRS Publication 502 excludes supplements unless a medical practitioner recommends them as treatment for a specific condition diagnosed by a physician, so check with your plan administrator first.

Is Nutrafol cheaper than finasteride?

No. Generic finasteride costs $16-$20/month at Ro and from $22/month at Hims as of September 11, 2026, well under Nutrafol's $79-$88/month. Nutrafol does not require a prescription and is not a drug - finasteride 1mg is FDA-approved for male pattern hair loss, while Nutrafol is a dietary supplement the FDA does not review for effectiveness - so the two are not directly interchangeable on cost or approach.

Does Nutrafol offer a cheaper multi-month plan?

Yes. As of September 11, 2026, a 3-month plan costs $224 and a 6-month plan costs $422, which Nutrafol labels as saving 15% and 20% against the one-time price. Confirm current bundle pricing directly with Nutrafol before you buy.

Sources & References

Our comparisons are informed by official sources and regulatory guidelines. We encourage you to verify information with authoritative sources.

Editorial Note: Researched and edited by our editorial team. AI tools assist with initial research and drafting; all content is fact-checked and edited by humans before publication. Learn more about our editorial standards

Start With a Top Hair Loss Provider

Our Top Choice
1

FDA-Approved Finasteride and Minoxidil - 100% Online, Free Shipping

  • Finasteride and minoxidil, plus the compounded Hair Hybrids blends, which the FDA has neither approved nor reviewed for safety, effectiveness, or quality
  • Oral finasteride tablets and topical minoxidil hold FDA approval for hair loss; the spray, chew and serum blends are the compounded Hair Hybrids and do not
  • Initial evaluation, ongoing check-ins and provider questions at no extra cost
  • Free shipping to your door - no insurance needed
9.4
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Best Value
2

Minoxidil From $12.67/mo - FDA-Approved Hair Regrowth

  • Minoxidil 2% topical solution from $12.67/mo; oral minoxidil from $29/mo, prescribed off-label for hair loss
  • Biotin + Minoxidil gummies and chews from $35/mo, compounded Hair Blends that carry no FDA approval and no FDA review of safety, effectiveness or quality
  • Postmenopausal serum pairing finasteride with minoxidil, a compounded blend; no topical finasteride product is FDA-approved
  • Topical minoxidil holds FDA approval for women's hair regrowth; the multi-ingredient blends do not
9.1
ExcellentScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★
Most Popular
3

Prescription-Strength Hair Regrowth - Free Discreet Shipping

  • Oral finasteride, oral minoxidil and topical minoxidil options
  • FDA-approved finasteride and topical minoxidil; oral minoxidil prescribed off-label
  • 100% online process with unlimited provider messaging
  • Free shipping in discreet packaging
9.3
OutstandingScore based on review by ManyTreatments editors, popularity, brand reputation, features and benefitsLearn how we score
★★★★★

Ready to Compare Providers?

Use our cost calculator to get personalized pricing estimates based on your insurance and location.

Disclaimer: Pricing information is based on publicly available data and may change without notice. Actual costs depend on your specific treatment plan, insurance coverage, and provider. Always verify current pricing with providers before purchasing. This article is for informational purposes only and is not financial or medical advice. We may receive compensation through affiliate links, which helps support our research.

Regulatory noticeRegulatory note (verified August 22, 2026): On September 9, 2025 the FDA sent Hims & Hers Health, Inc. a warning letter covering the Hims brand, MARCS-CMS 716567, drawn from a review of hims.com the previous month. Two lines about compounded semaglutide are quoted in it: "Same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." Compounded drug products are not FDA-approved, and the agency said phrasing of this sort suggests otherwise, which is what makes the products misbranded under FD&C Act sections 502(a) and 502(bb). A companion letter went to the same company that day for its Hers brand. No close-out letter appears in FDA’s index; treat this as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): Hers is a brand of Hims & Hers Health, Inc., and the FDA wrote to that company twice on September 9, 2025, once for each brand. The Hers letter, MARCS-CMS 716825, went to chief executive Andrew Dudum after an August 2025 review of forhers.com. It quotes two claims made for compounded semaglutide: "Weekly injectable GLP-1 with the same active ingredient as Ozempic and Wegovy" and "Clinically proven ingredients." The agency’s position is that compounded products carry no FDA approval, so claims like these imply a sameness with approved medicines that has not been established, making the products misbranded. FDA’s index lists neither a response nor a close-out letter, so the matter stands open. Read the FDA letter

Regulatory noticeRegulatory note (verified October 8, 2026): The FDA reviewed struthealth.com in December 2025 and, on February 20, 2026, issued Strut Health, LLC a warning letter, MARCS-CMS 721448. It raises two separate problems. Pictured product labels carry the "Strut" name, which the agency said represents Strut as the compounder of the semaglutide and tirzepatide products when it is not. The letter also quotes three claims from the site, among them "Generic Zepbound, Mounjaro", along with site copy naming semaglutide and tirzepatide as the active ingredient in the brand medications. Because compounded drugs hold no FDA approval, the FDA said wording of that kind implies one, and it cited misbranding under sections 502(a) and 502(bb) of the FD&C Act. The letter adds that introducing or delivering the products it identifies into interstate commerce is a prohibited act under section 301(a), that receiving them in interstate commerce and delivering or offering to deliver them also violates section 301(c), and that a compounded drug product must meet the conditions of section 503A or 503B of the FD&C Act to be exempt from certain requirements, including the new drug approval requirements. When we checked FDA's warning letter index for Strut Health, LLC on October 8, 2026 it showed no response letter and no close-out letter, so we treat the matter as open. Read the FDA letter

Regulatory noticeRegulatory note (verified August 22, 2026): A May 2026 review of maximustribe.com led the FDA to issue Maximus Health, Inc. warning letter MARCS-CMS 730095 on June 8, 2026. The language quoted here concerns effect and sourcing rather than ingredient comparison: "Clinically studied ingredients," "Clinically studied to help patients...," and "Proven to lose weight effectively," alongside a statement that the compounded products come from "FDA approved pharmacies." On that last point the agency was explicit that no FDA-approved or FDA-licensed designation exists for compounding pharmacies or outsourcing facilities, so describing one that way is misleading. Both findings were cited as misbranding under FD&C Act 502(a) and 502(bb). Nothing in FDA’s index records a close-out, so we log the matter as open. Read the FDA letter